Completed

A Study of Tirzepatide in Participants With Impaired Liver Function

I8F-MC-GPGQ - ClinicalTrials.gov - NCT03940742

The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants.
How long will I be in the trial?
The study will last about two months and will include five visits to the study center.
Email
Completed

A Study of Tirzepatide in Participants With Impaired Liver Function

I8F-MC-GPGQ - ClinicalTrials.gov - NCT03940742

The purpose of this study is to assess how fast tirzepatide gets into the blood stream and how long it takes the body to remove it in participants with impaired liver function compared to healthy participants.
How long will I be in the trial?
The study will last about two months and will include five visits to the study center.
Email

Key Requirements

Age :

18-85

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-85

Sex

All

Participants must

Participants must have a diagnosis of impaired liver function

Participants must NOT

Participants must not be taking blood sugar-lowering drugs, other than metformin - Female participants must not be able to get pregnant

Participants must not have a personal or family history of thyroid cancer

Participants must not have a history of or a diagnosis of disease of the pancreas

Participants must not have kidney disease

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

Tirzepatide

Could I receive a Placebo?

no

Enrollment Goal

42

Trial Dates

July 2019 - September 2020

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18-85

Sex

All

Participants must

Participants must have a diagnosis of impaired liver function

Participants must NOT

Participants must not be taking blood sugar-lowering drugs, other than metformin - Female participants must not be able to get pregnant

Participants must not have a personal or family history of thyroid cancer

Participants must not have a history of or a diagnosis of disease of the pancreas

Participants must not have kidney disease

Trial Summary

Conditions the trial is for

Adult Type 2 Diabetes

What the trial is testing?

Tirzepatide

Could I receive a Placebo?

no

Enrollment Goal

42

Trial Dates

July 2019 - September 2020

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Adult Type 2 Diabetes Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?